Salus, Ljubljana, D. D. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 13, 2021
Share
SALUS, Ljubljana, d. D. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was EUR 106.946 million compared to EUR 100.336 million a year ago. Operating income was EUR 5.293 million compared to EUR 2.775 million a year ago. Net income was EUR 4.824 million compared to EUR 2.075 million a year ago. Basic earnings per share from continuing operations was EUR 46.22 compared to EUR 19.89 a year ago.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Companyâs portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.
SALUS, LJUBLJANA, D. D. 
